Matthias Epple Selected Research

calcium phosphate

2/2022	Nanoparticles Carrying NF-κB p65-Specific siRNA Alleviate Colitis in Mice by Attenuating NF-κB-Related Protein Expression and Pro-Inflammatory Cellular Mediator Secretion.
1/2022	Reactivity of NK Cells Against Ovarian Cancer Cells Is Maintained in the Presence of Calcium Phosphate Nanoparticles.
1/2021	Silica-coated calcium phosphate nanoparticles for gene silencing of NF-κB p65 by siRNA and their impact on cellular players of inflammation.
1/2020	Reduction of inflammation in a chronic periodontitis model in rats by TNF-α gene silencing with a topically applied siRNA-loaded calcium phosphate paste.
1/2019	A Tumor-Peptide-Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy.
1/2018	Calcium phosphate particles stimulate interleukin-1β release from human vascular smooth muscle cells: A role for spleen tyrosine kinase and exosome release.
11/2017	Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation.
1/2016	Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
3/2015	Multifunctional calcium phosphate nanoparticles for combining near-infrared fluorescence imaging and photodynamic therapy.
1/2014	Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Epple Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 04/2005
10	Inflammation (Inflammations) 02/2022 - 08/2008
9	Infections 01/2020 - 11/2014
4	Virus Diseases (Viral Diseases) 01/2021 - 06/2015
3	AIDS-Related Complex (ARC) 09/2020 - 04/2020
3	Wounds and Injuries (Trauma) 11/2014 - 01/2014
2	Colitis 02/2022 - 09/2017
2	Persistent Infection 01/2021 - 01/2018
2	Periodontitis 01/2020 - 08/2019
2	Dentin Sensitivity 08/2019 - 01/2018
2	Atherosclerosis 01/2018 - 09/2002
2	Osteoporosis 01/2018 - 09/2002
2	Atherosclerotic Plaque (Atheroma) 01/2014 - 08/2008
1	Body Weight (Weight, Body) 02/2022
1	Ulcerative Colitis 02/2022
1	Disease Progression 02/2022
1	Ulcer 02/2022
1	Tooth Erosion 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Retroviridae Infections (Infection, Retrovirus) 01/2021
1	Hypoxia (Hypoxemia) 10/2020
1	Dental Plaque 03/2020
1	Chronic Periodontitis 01/2020
1	Tooth Wear 08/2019
1	Blindness (Hysterical Blindness) 01/2019
1	Osteoarthritis 01/2018
1	Metabolic Bone Diseases (Osteopenia) 01/2018
1	Lung Diseases (Lung Disease) 11/2017
1	Human Influenza (Influenza) 11/2017
1	Pneumonia (Pneumonitis) 11/2017
1	Necrosis 12/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2016
1	Skin Neoplasms (Skin Cancer) 06/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Communicable Diseases (Infectious Diseases) 06/2015
1	Neuroblastoma 03/2015

Drug/Important Bio-Agent (IBA)

13	calcium phosphateIBA 02/2022 - 09/2002
6	Small Interfering RNA (siRNA)IBA 02/2022 - 03/2015
5	Pharmaceutical PreparationsIBA 08/2021 - 04/2005
5	VaccinesIBA 01/2021 - 06/2015
4	SilverIBA 01/2020 - 01/2014
3	Dextran SulfateIBA 02/2022 - 01/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2018
3	Durapatite (Hydroxylapatite)IBA 04/2020 - 01/2018
3	CalciumIBA 03/2020 - 09/2002
2	Silicon Dioxide (Silica)FDA LinkGeneric 02/2022 - 01/2021
2	Biological ProductsIBA 01/2022 - 09/2020
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2022 - 03/2015
2	Coloring Agents (Dyes)IBA 10/2020 - 06/2016
2	TitaniumIBA 09/2020 - 09/2020
2	Ti-40Nb alloyIBA 09/2020 - 09/2020
2	Viral AntigensIBA 01/2019 - 01/2018
2	Interferon Type IIBA 01/2019 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 03/2015
2	AntigensIBA 01/2019 - 11/2014
2	PolyethyleneimineIBA 11/2017 - 01/2016
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2017 - 01/2016
2	CytokinesIBA 11/2017 - 01/2016
2	IonsIBA 11/2014 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2009
1	Proteins (Proteins, Gene)FDA Link 02/2022
1	FluoridesIBA 01/2022
1	GoldIBA 01/2022
1	Cytostatic AgentsIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 06/2021
1	poly-N-isopropylacrylamideIBA 06/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	tricalcium phosphateIBA 04/2020
1	AlloysIBA 04/2020
1	Phosphorus (Red Phosphorus)IBA 03/2020
1	Biocompatible Materials (Biomaterials)IBA 01/2020
1	Ointments (Pastes)IBA 01/2020
1	PeroxidesIBA 08/2019
1	ToothpastesIBA 08/2019
1	graphene oxideIBA 01/2019
1	NanovaccinesIBA 01/2019
1	AntibodiesIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2019
1	OsteoprotegerinIBA 01/2018
1	methacrylamideIBA 01/2018
1	LyasesIBA 01/2018
1	Parathyroid Hormone (Parathormone)IBA 01/2018
1	4- (2- (4- isopropylbenzamido)ethoxy)benzoic acidIBA 11/2017
1	Interleukin-6 (Interleukin 6)IBA 09/2017
1	Barium Sulfate (Barite)IBA 12/2016
1	ChemokinesIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 03/2015
1	SurvivinIBA 03/2015
1	Complementary DNA (cDNA)IBA 03/2015
1	Contrast MediaIBA 03/2015
1	Photosensitizing Agents (Photosensitizers)IBA 03/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
1	Lasers (Laser) 06/2021
1	Tooth Bleaching 08/2019
1	Immunotherapy 01/2019
1	Ovariectomy (Oophorectomy) 01/2018
1	Tattooing 06/2016
1	Aftercare (After-Treatment) 03/2015